GlassScriptPhysician profile
Heather L Benson
NPI 1780031146
$2,755.51
in general payments reported to CMS, 2019-2025
27 companies · $785 in 2025
The $785 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.81 · 2021: $30.37 · 2022: $770 · 2023: $553 · 2024: $564 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $525.62 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Omni Hysteroscope |
| Astellas Pharma US INC | $299.55 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $207.46 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $203.84 | 2022-2025 | |
| Abbvie INC. | $195.11 | 2022-2023 | Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $179.27 | 2022-2025 | Slynd |
| Pfizer INC. | $177.33 | 2021-2025 | |
| Intuitive Surgical, INC. | $138.43 | 2020-2022 | |
| Coopersurgical, INC. | $123.73 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Gynesonics, INC. | $110.96 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Biogen, INC. | $68.62 | 2025 | Zurzuvae |
| Organon LLC | $66.64 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $60.38 | 2023-2025 | |
| Millicent US INC | $58.29 | 2024-2025 | Intrarosa, Femlyv |
| Pacira Pharmaceuticals Incorporated | $56.13 | 2022-2023 | Exparel |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $50.75 | 2023 | |
| Myovant Sciences INC. | $30.81 | 2022 | |
| Meditrina | $28.84 | 2024 | |
| Kerecis Limited | $28.75 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Dexcom, INC. | $24.65 | 2025 | Dexcom G6 Transmitter |
| Covidien LP | $21.00 | 2020 | |
| Mylan Pharmaceuticals INC. | $19.05 | 2022 | |
| Abbott Laboratories | $18.91 | 2022 | |
| Solventum Corporation | $17.94 | 2024 | Ioban 2, 3m Duraprep Surgical, Prevena |
| Shield Therapeutics INC | $17.90 | 2022 | |
| Optumhealth Care Solutions, LLC | $13.50 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Ethicon US, LLC | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.